Effect of topical application of terbinafine on fungal keratitis

Chinese Medical Journal

Volumn 122, Issue 16, 2009, Pages 1884-1888

  Liang, Qing Feng ^a   Jin, Xiu Ying ^a   Wang, Xiang Lan ^a   Sun, Xu Guang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Fungal; Keratitis; Natamycin; Terbinafine; Therapy

Indexed keywords

AMPHOTERICIN B; ATROPINE; FLUCONAZOLE; IODINE; ITRACONAZOLE; NATAMYCIN; TERBINAFINE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; CHINA; CONTROLLED STUDY; CORNEA STROMA; CORNEA ULCER; DEBRIDEMENT; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EVENING DOSAGE; FEMALE; FUNGUS CULTURE; FUNGUS ISOLATION; FUSARIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MYCOSIS; NONHUMAN; RETROSPECTIVE STUDY; SMEAR; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTIFUNGAL AGENTS; ASPERGILLUS; FUSARIUM; HUMANS; KERATITIS; NAPHTHALENES; NATAMYCIN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70349557783     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.16.009     Document Type: Article

References (19)

1. Xie L, Zhai H, Zhao J, Sun S, Shi W, Dong X. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. Am J Ophthalmol 2008; 146: 260-265.
2. Sun X, Wang Z, Luo S, Jin X, Zhang W, Li R, et al. Etiological analysis on the ocular fungal infection. Chin J Ophthalmol (Chin) 2002; 38: 405-407.
3. Korting HC, Kiencke P, Nelles S, Rychlik R. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis. Am J Clin Dermatol 2007; 8: 357-364.
4. Xie L, Zhong W, Shi W, Sun S. Spectrum of fungal keratitis in North China. Ophthalmology 2006; 113: 1943-1948.
5. Xuguang S, Zhixin W, Zhiqun W, Shiyun L, Ran L. Ocular fungal isolates and antifungal susceptibility in Northern China. Am J Ophthalmol 2007; 143: 131-133.
6. Wang XL, Peng SL, Zhou Y, Luo SY, Weng SM. Experimental study on the treatment of keratomycosis with allylamines. Opthalmol CHN (Chin) 1998; 7: 46-48.
7. Wang ZX, Wang ZQ, Luo SY, Ran L, Den SJ, Sun XG. Etiological analysis of ocular fungal isolates and susceptibility in vitro. Chin Ophthal Res (Chin) 2007; 25: 145-148.
8. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. NCCLS: Wayne, Pennsylvania; 2002: 1-30.
9. Leck AK, Thomas PA, Hagan M, Kaliamurthy J, Ackuaku E, John M. Aetiology of suppurative corneal ulcers in Ghana and South India, and epidemiology of fungal keratitis. Br J Ophthalmol 2002; 86: 1211-1215.
10. Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao GN. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea 2002; 21: 555-559.
11. Rohini G, Murugeswari P, Prajna NV, Lalitha P, Muthukkaruppan V. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis. Cornea 2007; 26: 207-211.
12. Gopinathan U, Ramakrishna T, Willcox M, Rao CM, Balasubramanian D, Kulkarni A. Enzymatic, clinical and histologic evaluation of corneal tissue in experimental fungal keratitis in rabbits. Exp Eye Res 2001; 72: 433-442.
13. Prajna NV, John RK, Nirmalan PK, Lalitha P, Srinivasan M. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br J Ophthalmol 2003; 87: 1235-1237.
14. Manzouri B, Vafidis GC, Wyse RK. Pharmacotherapy of fungal eye infection. Expert Opin Pharmacother 2001; 2: 1849-1857.
15. Cribier BJ, Bakshi R. Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections. Br J Dermatol 2004; 150: 414-420.
16. N'diaye B, Dieng MT, Perez A, Stockmeyer M, Bakshi R. Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int J Dermatol 2006; 45: 154-157.
17. Sun XG, Wang ZX, Wang ZQ, Deng SJ, Li R, Luo SY. Pharmacokinetics of terbinafine in the rabbit ocular tissues after topical administration. Ophthalmic Res 2007; 39: 81-83.
18. Wang ZQ, Sun XG, Li R,Wu YY. The study on ocular irritation with tebinafine ey drops in rabbit keratitis model. Opthalmol CHN (Chin) 2004; 13: 255-256.
19. Faergemann J, Zehender H, Denouel J, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks. Acta Derm Venereol 1993; 73: 305-309.